WEBS0104

Information about WEBS0104

Published on April 16, 2008

Author: Arley33

Source: authorstream.com

Content

No time to wait: taking legal action to increase access to HIV medicines:  No time to wait: taking legal action to increase access to HIV medicines Jonathan Berger Senior Researcher AIDS Law Project SOUTH AFRICA Bridging Session Access to Treatment: People Before Trade Wednesday, August 16th 2006 XVI International AIDS Conference _________________________________________________________ Overview of presentation:  Overview of presentation _________________________________________________________ South African context Access concerns Political context Constitutional framework Case studies Hazel Tau vs. GSK and Boehringer Ingelheim BMS’s Amphotericin B (Fungizone®) Concluding thoughts South African context:  South African context _________________________________________________________ Access concerns Excessive pricing Sustainability of supply Political context Government inaction Civil society leadership Constitutional framework Socio-economic rights protections Positive state obligations Interpretation of all legislation Case studies:  Case studies _________________________________________________________ Hazel Tau vs. GSK and Boehringer Ingelheim Focus on three essential ARVs: AZT, 3TC and NVP Patent-protected No generic competition Excessive private sector prices BMS’s Amphotericin B (Fungizone®) Gold standard for cryptococcal meningitis Off-patent No generic competition Excessive public and private sector prices Tau v GSK and BI:  Tau v GSK and BI _________________________________________________________ GSK and BI alleged to have “engaged in excessive pricing of ARVs to the detriment of consumers” Conduct was alleged to be – Directly responsible For the premature, predictable and avoidable deaths Of people living with HIV/AIDS In contravention of section 8(a) of the Competition Act, 89 of 1998 As interpreted in light of the Constitution What had to be proven?:  What had to be proven? _________________________________________________________ Charging a price for a good or service which – Bears no reasonable relation to the economic value of that good or service; and Is higher than this value What makes up the economic value? Manufacturing costs R&D costs (where applicable) Licensing costs (where applicable) Reasonable profits ??? Reasonable relation = balancing of rights Resolution by settlement:  Resolution by settlement _________________________________________________________ Matter settled in December 2003 Avoided Competition Tribunal public hearing Complex legal issues remain unresolved Implementation of settlement Excessive pricing complaint, but licensing solution Reasonable terms and conditions Public and private sectors Imports and/or local production of products (including FDCs) Exports of locally produced ARVs to sub-Saharan Africa 5% royalty maximum (including for FDCs) Price reductions:  Price reductions _________________________________________________________ Amphotericin B:  Amphotericin B _________________________________________________________ Need for access Cryptococcal meningitis has 25 – 40% mortality rate in people living with HIV/AIDS Limited use in public sector primarily as result of price Private sector price even higher Legal action Threat of excessive pricing action Request for justification of pricing policy Matter settled after series of letters Private/public divide overcome Price reduction of between 80% and 85% Concluding thoughts:  Concluding thoughts _________________________________________________________ Civil society took the lead No government-issued licences under Patents Act Not even threats of issuing licences State willing to let civil society do its “dirty work” Chilling effect of TRIPs+ compulsory licensing provisions Failure to implement Doha Declaration No licences issued by courts on any patented products No applications for licences by generic manufacturers of ARVs Need for regulatory reform Express licensing remedy for excessive pricing Implement the Doha Declaration Slide11:  Go to www.AIDStruth.org for accurate information on HIV/AIDS and to learn about how AIDS denialists twist the truth and peddle lies. AIDS DENIALISM

Related presentations


Other presentations created by Arley33

Cold Weather Safety
02. 01. 2008
0 views

Cold Weather Safety

TEN RULES OF FIREARM SAFETY
26. 02. 2008
0 views

TEN RULES OF FIREARM SAFETY

How to succeed
02. 10. 2007
0 views

How to succeed

The Internet Motion Sensor
07. 10. 2007
0 views

The Internet Motion Sensor

Xraydiffraction 2007
12. 10. 2007
0 views

Xraydiffraction 2007

CHM1222Chromatograph yTheory
16. 10. 2007
0 views

CHM1222Chromatograph yTheory

student chap21
17. 10. 2007
0 views

student chap21

Imperialism and World War I
22. 10. 2007
0 views

Imperialism and World War I

kr spam hacking status
11. 09. 2007
0 views

kr spam hacking status

tiger
11. 09. 2007
0 views

tiger

019
11. 09. 2007
0 views

019

tsg0502 10
09. 10. 2007
0 views

tsg0502 10

atomsmoleculesandions
16. 10. 2007
0 views

atomsmoleculesandions

wipo ip mct 05 3
25. 10. 2007
0 views

wipo ip mct 05 3

Adam Smith Krestinskiy
26. 10. 2007
0 views

Adam Smith Krestinskiy

ROK CP
11. 09. 2007
0 views

ROK CP

R LANQUAR FEMIP
23. 10. 2007
0 views

R LANQUAR FEMIP

rmode potsdam04
15. 11. 2007
0 views

rmode potsdam04

how to spot a turkey
26. 11. 2007
0 views

how to spot a turkey

052407 Gascon
14. 12. 2007
0 views

052407 Gascon

15 whiteCWppt
22. 11. 2007
0 views

15 whiteCWppt

PPA724 queries
28. 09. 2007
0 views

PPA724 queries

IPv6 Forum World Congress Europe
07. 01. 2008
0 views

IPv6 Forum World Congress Europe

v short lcg
17. 10. 2007
0 views

v short lcg

click construct
02. 11. 2007
0 views

click construct

symp apr 02 page e
15. 10. 2007
0 views

symp apr 02 page e

Model PÃster horitzontal
16. 11. 2007
0 views

Model PÃster horitzontal

NTS 101
16. 02. 2008
0 views

NTS 101

ENG 40B DR Mathias P Point
20. 02. 2008
0 views

ENG 40B DR Mathias P Point

Nichols Schwartz 05 Bowenian
24. 02. 2008
0 views

Nichols Schwartz 05 Bowenian

swartz
17. 10. 2007
0 views

swartz

ON VECTOR 022707 final
19. 10. 2007
0 views

ON VECTOR 022707 final

EducationalPowerpoint
19. 11. 2007
0 views

EducationalPowerpoint

lectures256p3
07. 12. 2007
0 views

lectures256p3

W03 Late Ming 3 Lives b
26. 03. 2008
0 views

W03 Late Ming 3 Lives b

germany 1 27 05
07. 04. 2008
0 views

germany 1 27 05

EH HL3 MP TWG1
30. 03. 2008
0 views

EH HL3 MP TWG1

ustrans
10. 04. 2008
0 views

ustrans

CAP12PP2
13. 04. 2008
0 views

CAP12PP2

Dr Jongkon
14. 04. 2008
0 views

Dr Jongkon

Deb Tairas presentation
17. 04. 2008
0 views

Deb Tairas presentation

silverman 06
19. 02. 2008
0 views

silverman 06

SAB EPEAT 050608
28. 04. 2008
0 views

SAB EPEAT 050608

Macsim Mihai
18. 03. 2008
0 views

Macsim Mihai

martes manyana 5a presentacion
28. 12. 2007
0 views

martes manyana 5a presentacion

korea otonwu06
11. 09. 2007
0 views

korea otonwu06

larsen jsm2003
29. 10. 2007
0 views

larsen jsm2003

PHYCS 199B Oct 29 2002
15. 10. 2007
0 views

PHYCS 199B Oct 29 2002

Ryan Henry
23. 12. 2007
0 views

Ryan Henry

ewilaya eforumALAMI 2007
23. 10. 2007
0 views

ewilaya eforumALAMI 2007

ELAN
05. 10. 2007
0 views

ELAN

BELIZE
22. 10. 2007
0 views

BELIZE

Sheena Kim
11. 09. 2007
0 views

Sheena Kim

moscow11
15. 10. 2007
0 views

moscow11

Gavrilova PAA 2005
12. 10. 2007
0 views

Gavrilova PAA 2005

mirror darts
29. 12. 2007
0 views

mirror darts

bruxelles dd
17. 10. 2007
0 views

bruxelles dd

EC Baron DCC abridged
11. 03. 2008
0 views

EC Baron DCC abridged

Image53967
07. 01. 2008
0 views

Image53967

GSA dlese teaching boxes
30. 10. 2007
0 views

GSA dlese teaching boxes

Illarionovs Projections
26. 10. 2007
0 views

Illarionovs Projections